Glycated lysine residues: A marker for non-enzymatic protein glycation in age-related diseases

Disease Markers

Volumn 30, Issue 6, 2011, Pages 317-324

  Ansari, Nadeem A ^a   Moinuddin, ^a   Ali, Rashid ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

AGEs; Amadori products; autoantibodies; biomarker; diabetes; Glycation; Lysine

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ARGININE; AUTOANTIBODY; CHLOROGENIC ACID; COLLAGEN; CRYSTALLIN; CYSTEINE; ERYTHROCYTE MEMBRANE PROTEIN 1; GLUCOSE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED PROTEIN; GLYOXAL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HISTONE; HISTONE H1; HISTONE H2B; HISTONE H3; HUMAN SERUM ALBUMIN; HYDROXYL RADICAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INSULIN; LOW DENSITY LIPOPROTEIN; LYSINE; POLYCLONAL ANTIBODY; SCHIFF BASE; SERUM ALBUMIN; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; AMADORI REARRANGEMENT; ANTIGENICITY; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; CATARACT; COMPETITIVE INHIBITION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MEMBRANE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS;

EID: 79960718937     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0791     Document Type: Article

References (83)

1. A.S. Acharya and J.M. Manning, Amadori rearrangement of glyceraldehyde-hemoglobin Schiff base adducts, Journal of Biological Chemistry 255 (1980), 7218-7224.
2. M.S. Ahmad, M. Pischetsrieder and N. Ahmed, Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts, European Journal of Pharmacology 56 (2007), 32-38. (Pubitemid 46435858)
3. N. Ahmed, U. Ahmed, P.J. Thornalley, K. Hager, G. Fleischer and G. Munch, Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment, Journal of Neurochemistry 92 (2005), 255-263. (Pubitemid 40194017)
4. N.J. Akhtar, T. Sun and J. Liang, Conformational study of Ne-(carboxymethyl)lysine adducts of recombinant a-crystallins, Current Eye Research 18 (1999), 270-276. (Pubitemid 29237886)
5. N.A. Ansari, Moinuddin, Alam K, Ali A. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: Role of protein glycation in the disease process, Human Immunology 70 (2009), 417-424.
6. N.A. Ansari, Moinuddin. Identification of Amadori-modified immunoglobulin G in type 2 diabetic patients with secondary complications, IUBMB Life 61(3) (2009), 309-310.
7. N. Araki, R. Shibayama, Y. Ejima, R. Nagai, T. Araki, H. Saya and S. Horiuchi, Study of autoantibodies against advanced glycation endproducts of the Maillard reaction, International Congress Series 123 (2001), 49-58.
8. O.K. Argirov, B. Lin and B.J. Ortwert, 2-Ammonio-6-(3-oxidopyridinium-1- yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses, Journal of Biological Chemistry 8 (2004), 6487-6496.
9. D.A. Armbruster, Fructosamine: structure, analysis and clinical usefulness, Clinical Chemistry 33 (1987), 2153-2163.
10. B.E. Bachmeier, A.G. Nerlich, H. Rohrbach, E.D. Schleicher and E.D. Friess, Maillard products as biomarkers in cancer, Annals of the New York Academy of Sciences 1126 (2008), 283-287. (Pubitemid 351589319)
11. B. Bouma, L.M.J. Kroon-Batenburg, Y. Wu, B. Brunjes, G. Posthuma, O. Kranenburg, P.G. Groot, E.E. Voest and M.F.B.G. Gebbink, Glycation induces formation of amyloid cross-/3 structure in albumin, Journal of Biological Chemistry 278(43) (2003), 41810-41819. (Pubitemid 37310441)
12. R. Bei, L. Masuelli, C. Palumbo, M. Modesti and A. Modesti, A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth, Cancer Letters 281 (2009), 8-23.
13. H.F. Bunn, R. Shapiro, M. McManus, L. Garlick, M.J. McDonald, P.M. Gallop and K.H. Gabbay, Structural heterogeneity of human hemoglobin A due to non-enzymatic glycosylation, Journal of Biological Chemistry 254 (1979), 3892-3898. (Pubitemid 9178801)
14. D. Cervantes-Laurean, E.L. Jacobson and M.K. Jacobson, Glycation and Glycoxidation of histonesby ADP-ribose, Journal of Biological Chemistry 271 (1996), 10461-10469.
15. D. Cervantes-Laurean, M.I. Roberts and E.L. Jacobson, Nuclear proteasome activation and degradation of carboxymethy-lated histones in human keratinocytes following glyoxal treatment, Free Radical Biology and Medicine 38 (2005), 786-795. (Pubitemid 40249749)
16. J.R. Chen, S. Takahashi, M. Suzuki, K. Kushida, S. Miyamoto and T. Inoue, Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis, Journal of Rheumatology 25 (1998), 2440-2444. (Pubitemid 28551864)
17. M.P Cohen, E. Hud and V.Y Wu, Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin, Kidney Intenational 45 (1994), 1673-1679. (Pubitemid 24207503)
18. M.P. Cohen, E. Hud and E. Shea, Rate of formation of glycated albumin revisited and clinical implications, Journal of Diabetes and Metabolism 1 (2010), 102, (doi:10.4172/2155-6156.1000102).
19. R. Dolhofer and O.H. Weiland, Preparation and biological properties of glycosylated albumin, FEBS Letters 100 (1979), 133-136. (Pubitemid 9147379)
20. A. Dotevall, J. Hulthe, A. Rosengren, O. Wiklund and O. Wil-helsen, Autoantibodies against oxidized low-density lipopro-tein and C-reactive protein are associated with diabetes and myocardial infarction in women, Clinical Science 101 (2001), 523-531. (Pubitemid 33032997)
21. ε(Carboxymethy1)hydroxylysine in human skin collagen, Biochemistry 30 (1991), 1205-1210.
22. A. Frolov, D. sdzxc Singer and R. Hoffmann, Site-specific synthesis of Amadori-modified peptides on solid phase, Journal of Peptide Science 12 (2006), 389-395. (Pubitemid 43933226)
23. M.-X. Fu, K.J. Wells-knecht, J.A. Blackledge, T.J. Lyons, S.R. Thorpe and J.W. Baynes, Glycation, glycoxidation and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction, Diabetes 43 (1994), 676-683. (Pubitemid 24138781)
24. S.Y. Goh and M.E. Cooper, Clinical review: the role of advanced glycation endproducts in progression and complications of diabetes, Journal of Clinical Endocrinology and Metabolism 93 (2008), 1143-1152. (Pubitemid 351519698)
25. A. Gugliucci, D.H.M. Bastos, J. Schulze and M.F.F. Souza, Caffeic and cholorogenic acids in Ilex paraguariensis are the main inhibitors of AGE generation by methylglyoxal in model proteins, Fitoterapia 80 (2009), 339-344.
26. ε-(carboxymethy1)lysine in rat serum and urine proteins with aging: Link with glycoxidative damage accumulation in kidney, Archives of Biochemistry and Biophysics 411 (2003), 215-222. (Pubitemid 36298649)
27. A. Jafarnejad, S.J. Bathaie, M. Nakhjavani, M.J. Hassan and M.J. Banasadegh, The improvement effect of L-lysine as a chemical chaperone on STZ-induced diabetic rats, protein structure and function, Diabetes/Metabolism Research and Reviews 24 (2008), 64-73. (Pubitemid 351176002)
28. A. Jaleel, P. Halvatsiotis and B. Williamson, Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment, Diabetes Care 28 (2005), 645-652. (Pubitemid 40315326)
29. K. Jobst, A. Lakattos and A. Horvath, Glycohistones in diabetic human liver, Clinica Chimica Acta 200 (1991), 231-232.
30. K. Jobst and K. Lakattos, The liver cell histones of diabetic patients contain AGEs which may be lipofuscin components, Clinica Chimica Acta 256 (1996), 203-204.
31. K. Kalia, S. Sharma and S. Mistry, Non-enzymatic glycosy-lation of immunoglobulins in diabetic nephropathy, Clinica Chimica Acta 347 (2004), 169-176. (Pubitemid 39099619)
32. H. Kaneshige, Nonenzymatic glycosylation of serum Ig G and its effect on antibody activity in patients with diabetes mellitus, Diabetes 36 (1987), 822-828. (Pubitemid 17145303)
33. M.W.A. Khan, S. Sherwani, W.A. Khan and Ali R. Moinud-din, Characterization of hydroxyl radical modified GAD65: A potential autoantigen in type 1 diabetes, Autoimmunity 42 (2009), 150-158.
34. M. Kirstien, J. Brett, S. Radoff, S. Ogawa, D. Stern and H. Vlassara, Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging, Proceedings of the National Academy of Sciences USA 87 (1990), 9010-9014. (Pubitemid 120007639)
35. B.S. Kristal and B.P. Yu, An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions, Jo- urnal of Gerontology 47(4) (1992), B107-B114.
36. B.T. Kurien and R.H. Scofield, Autoimmunity and oxidatively modified autoantigens, Autoimmun Rev 7 (2008), 567-573.
37. A. Lapolla, C. Gerhardinger, L. Baldo, D. Fedele, D. Favretto, R. Seraglia et al., Pyrolysis/gas chromatography/mass spec-trometry in the analysis of glycated poly-L-lysine, Organic Mass Spectrometry 27 (1992), 183-187.
38. J.N. Liang, Circular dichroism of the non-enzymatic browning products of poly-L-lysineand albumin, International Journal of Biological Macromolecules 12 (1990), 273-277. (Pubitemid 20269617)
39. S. Ligier, P.R. Fortin and M.M. Newkirk, A new antibody in rheumatoid arthritis targeting glycated Ig G: Ig M anti-Ig G-AGE, British Journal of Rheumatology 37 (1998), 1307-1314.
40. M. Lucey, M.M. Newkirk, C. Neville, K. Lepage and P.R. Fortin, Association between Ig M response to Ig G damaged by glyoxidation and disease activity in rheumatoid arthritis, Journal of Rheumatology 27 (2000), 319-323. (Pubitemid 30095458)
41. T. Menini, A. Gugliucci, Y.K. Sodahlon, A.J.C. Stahl, J.F. Blickle and J.M. Brogard, Glycated immunoglobulin M in diabetic patients, Annals of Biological Chemistry 50 (1993), 887-891. (Pubitemid 24044533)
42. J.A. Miller, E. Gravelles and F.H. Bunn, Nonenzymatic glyco-sylation of erythrocyte membrane proteins. Relevance to diabetes, Journal of Clinical Investigation 65 (1980), 896-901. (Pubitemid 10144065)
43. T. Miyata, N. Ishiguro, Y. Yasuda, T. Ito, M. Nangaku, H. Iwa-ta and K. Kurukawa, Increased pentosidine, an AGE, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers, Biochemical Biophysical Research Communication 244 (1998), 45-49. (Pubitemid 28419898)
44. T. Miyata, N. Ishikawa and C.Y. De Strihou, Carbonyl stress and diabetic complications, Clinical Chemistry and Laboratory Medicine 41 (2003), 1150-1158. (Pubitemid 37265693)
45. V.M. Monnier, Nonenzymatic glycosylation, the Maillard reaction and aging process, Journal of Gerontology 45 (1990), B105-B111. (Pubitemid 20224052)
46. V.M. Monnier, G.T. Mustata, K.L. Biemel, O. Reihl, M.O. Lederer, D. Zhenyu and D.R. Sell, Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes, Annals of the New York Academy of Sciences 1043 (2005), 533-544.
47. V.M. Monnier, D.R. Sell, Z. Dai, I. Nemet, F. Collard and F. Zhang, The role of the Amadori product in complications of diabetes, Annals of the New York Academy of Sciences 1126 (2008), 81-88. (Pubitemid 351589314)
48. G. Munch, D. Schicktanz, A. Behme, M. Gerlach, P. Riederer, P. Palm et al., Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library, Nature Biotechnology 17 (1999), 1006-1010. (Pubitemid 29474858)
49. T. Myint, S. Hoshi, T. Ookawara, N. Miyazawa, K. Suzuki and N. Taniguchi, Immunological detection of glycated proteins in normal and streptozotocin- induced diabetic rats using anti hexitol-lysine Ig G, Biochimica Biophysica Acta 1271 (1995), 73-79.
50. ε-(carboxymethyl)lysine formation from Amadori product, Biochemical Biophysical Research Communication 234 (1997), 167-172. (Pubitemid 27267554)
51. M.M. Newkirk, R. Goldbach-Mansky, J. Lee, J. Hoxworth, A. McCoy, C. Yarboro et al., Advanced glycation end-product (AGE)-damaged Ig G and Ig M autoantibodies to Ig G-AGE in patients with early synovitis, Arthritis Research and Therapy 5 (2003), 82-90.
52. J. Ni, X. Yuan, J. Gu, X. Yue, X. Gu, R.H. Nagaraj and J.W. Crabb, Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration, Molecular and Cellular Proteomics 8 (2009), 1921-1933.
53. R. Ramasamy, S.J. Vannucci, S.S.D. Yan, K. Herold, S.F. Yan and A.M. Schmidt, Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegenera-tion, and inflammation, Glycobiology 15(7) (2005), 16R-28R. (Pubitemid 41417992)
54. M. Ranjan, S. Nayak and B.S. Rao, Immunochemical detection of glycated β- and γ-crystallins in lens and their circulating autoantibodies (Ig G) in streptozocin induced diabetic rat, Molecular Vision 12 (2006), 1077-1085. (Pubitemid 44400478)
55. M. Ranjan, S. Nayak, T. Kosuri and B.S. Rao, Immunochemical detection of glycated lens crystallins and their circulating autoantibodies in human serum during aging, Molecular Vision 14 (2008), 2056-2066.
56. Z. Rasheed and R. Ali, Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes melli-tus: Biochemical and immunological studies, Life Sciences 79 (2006), 2320-2328. (Pubitemid 44666070)
57. Z. Rasheed, L. Kumar, S. Abbas, I. Prasad, N.A. Ansari and R. Ahmad, Advanced glycation end-products damaged Ig G, a target for circulating autoantibodies in patients with type 1 diabetes mellitus, Open Glycoscience 2 (2009), 1-8.
58. T. Richter, G. Munch, H. Luth, T. Arendt, R. Kientsch-Engel, P. Stahl, D. Fengler and B. Kuha, Immunochemical cross-reactivity of antibodies specific for "advanced glycation end-products" with advanced lipoxidation endproducts", Neurobi-ology of Aging 26 (2005), 465-474. (Pubitemid 40093930)
59. C.G. Schalkwijk, N. Chaturvedi, H. Twaafhoven, V.W. Van Hinsbergh and C.D. Stehouwer, Amadori albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetes, European Journal of Clinical Investigation 32 (2002), 500-506. (Pubitemid 36223420)
60. C.G. Schalkwijk, N. Ligtvoet, H. Twaafhoven, A. Jager, H.G.T. Blaauwgeers, R.O. Schlingemann et al., Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropa-thy and localization in retinal capillaries, Diabetes 48 (1999), 2446-2453. (Pubitemid 30395438)
61. C.G. Schalkwijk and T. Miyata, Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics, Amino Acids (2010) (doi:10.1007/ s00726-010-0779-9).
62. ε-(carboxymethyl)lysine in human tissues in diabetes and aging, Journal of Clinical Investigation 99 (1997), 457-468. (Pubitemid 27414803)
63. U. Schwarzenbolz, S. Mende and T. Henle, Model studies on protein glycation, Annals of the New York Academy of Sciences 1126 (2008), 248-252.
64. R.H. Scofield, Autoantibodies as predictors of disease, The Lancet 363 (2004), 1544-1546. (Pubitemid 38596835)
65. R.D. Semba, S. Bandinelli, K. Sun, J.M. Guralnik and L. Fer-rucci, Plasma carboxymethyl-lysine, an advanced glycation endproduct and all-cause and cardiovascular disease mortality in older community dwelling adults, Journal of the American Geriatrics Society 57 (2009), 1874-1880.
66. J.S. Sjoberg and S. Bulterijs, Characteristics, formation, and pathophysiology of glucosepane: a major protein cross-link, Rejuvenation Research 12 (2009), 137-148.
67. N. Shaklai, R.L. Garlick and F.H. Bunn, Nonenzymatic gly-cosylation of human serum albumin alters its conformation and function, Journal of Biological Chemistry 259 (1984), 3812-3817. (Pubitemid 14170093)
68. ε-(Carboxymethyl)lysine: An advanced gly-cation endproduct of the Maillard reaction 48 (1999), 1842-1849.
69. H.M. Sims, A.L. Birdwell, K.E. O'Reilley, A. Bwashi and B.D. Wing, Inhibition of protein glycation with varying concentrations of lysine, The FASEB Journal 22 (2008), 1123.15.
70. J.H. Sohn, J.O. So, H. Kim, E.J. Nam, H.J. Ha, Y.H. Kim and I. Mook-Jung, Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice, Biochemical Biophysical Research Communication 361 (2007), 800-804. (Pubitemid 47238053)
71. J.V. Stevens, C.A. Rouzer, V.M. Monnier and V.M. Cerami, Diabetic cataract formation: potential role of glycosylation of lens crystallins, Proceedings of the National Academy of Sciences USA 75 (1978), 2918-2922. (Pubitemid 8378735)
72. C.E. Taplin and J.M. Barker, Autoantibodies in type 1 diabetes, Autoimmunity 41 (2008), 11-18.
73. P.J. Thornalley, S. Battah and S. Ahmed, Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry, Biochemical Journal 375 (2003), 581-592. (Pubitemid 37433506)
74. P.J. Thornalley and N. Rabbani, Therapy: Vitamin B(6), B(9) and B(12) in diabetic nephropathy-beware, Nature Review Endocrinology 6 (2010), 477-478.
75. S.M. Trigwell, P.M. Radford, S.R. Page, A.C. Loweth, R.F.L. James and N.G. Morgan, Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by anti- bodies from patients with type 1 diabetes mellitus, Clin Exp Immunol 126 (2001), 242-249. (Pubitemid 32995138)
76. Z. Turk, Glycation and complications of diabetes, Diabetolo-gia Croatica 30 (2001), 49-54.
77. Z. Turk, S. Ljubic, N. Turk and B. Benko, Detection of autoan-tibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus, Clinica Chimica Acta 303 (2001), 105-115. (Pubitemid 32121812)
78. P. Ulrich and A. Cerami, Protein glycation, diabetes and aging, Recent Progress in Hormone Research 56 (2001), 1-22.
79. J.W.J. Van Heijst, H.W.M. Niessen, K. Hoekman and C.G. Schalkwijk, Advanced glycation endproducts in human tissues, Annals of the New York Academy of Sciences 1043 (2005), 725-733.
80. N.G. Watkins, S.R. Thorpe and J.W. Baynes, Glycation of amino groups in protein, Journal of Biological Chemistry 260 (1985), 10629-10636.
81. M.E. Weksler and M.E. Goodhardt, Do age-associated changes in 'physiologic' autoantibodies contribute to infection, atherosclerosis, and Alzheimer's disease? Experimental Gerontology 37 (2002), 971-979.
82. G.T. Wondrak, D. Cervantes-Laurean, E.L. Jacobson and M.K. Jacobson, Histone carbonylation in vivo and in vitro, Biochemical Journal 351 (2000), 769-777.
83. D. Yin and D. Chen, The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions, Experimental Gerontology 40 (2005), 455-465. (Pubitemid 40884498)